Actavis Net Revenue Increases 59% to $2.779 Billion in Fourth Quarter 2013LEARN MORE>
Actavis Completes Forest Laboratories Acquisition
>Go!

Executive Leadership and Directors

Executive Leadership
Paul M. BisaroExecutive Chairman, Actavis plc
Brent L. SaundersCEO & President
Robert A. StewartEVP & President, Generic and Global Operations
Maria Teresa HiladoEVP, Chief Financial Officer
Paul NavarreEVP & President, International Brands
William MeuryEVP & President, Branded Pharma
Philippe SchaisonEVP & President, Allergan Medical
Karen LingEVP, Chief Human Resources Officer
A. Robert D. BaileyEVP, Chief Legal Officer & Corporate Secretary
Jonathon L. KellermanEVP, Global Chief Compliance Officer
Alex KellyEVP, Chief Communications Officer
Sigurd KirkEVP, Corporate Business Development
David Nicholson,Ph.D.EVP, Brand R&D
Sanjiv PatelEVP, Chief Strategy Officer
Directors
Nesli Basgoz, M.D.Associate Chief for Clinical Affairs, Division of Infectious Diseases, Massachusetts General Hospital (MGH)
Paul M. BisaroExecutive Chairman, Actavis plc
James H. BloemSenior Vice President, Chief Financial Officer and Treasurer, Humana Inc.
Christopher W. BodineFormer President, Health Care Services for CVS Caremark Corporation
Christopher J. CoughlinFormer Executive Vice President and Chief Financial Officer, Tyco
Michael R. GallagherFormer Chief Executive Officer and Director of Playtex Products, Inc.
Catherine  M.  KlemaLead Independent Director – President, Nettleton Advisors LLC
Peter J. McDonnell, M.D.Director and William Holland Wilmer Professor of the Wilmer Eye Institute of the Johns Hopkins University School of Medicine
Patrick J. O’SullivanFormer Chief Executive Officer, LEO Pharma Ireland
Brent L. SaundersCEO & President, Actavis plc
Ronald R. TaylorPresident, Tamarack Bay LLC
Fred G. WeissManaging Director, FGW Associates, Inc.
ELECTRONIC ENROLLMENT